Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer
NCT05450484
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
Fluorescence endoscopy using durvalumab-680LT
Sponsor
University Medical Center Groningen
Collaborators
[object Object]